|
KMID : 1011120200130030001
|
|
Bioethics Policy Studies
2020 Volume.13 No. 3 p.1 ~ p.25
|
|
|
Research Ethics in COVID-19(SARS-CoV-2) Vaccine Study
|
|
Jung Jun-Ho
Kim Ock-Joo
|
|
|
Abstract
|
|
|
|
The new coronavirus in China in December 2019 is spreading rapidly all over the world, causing a global emergency with a growing number of deaths. Currently, the only way to end the COVID-19 pandemic is to acquire herd immunity by developing effective vaccines. The ethical challenge facing the world today is the rapid development and dissemination of safe and effective vaccines to end the pandemic. For this, global solidarity and cooperation are critically important. Policy makers and regulators around the world are trying to harmonize the regulatory framework. Industry and research institutions are accelerating research on therapies and vaccines against COVID-19 through data sharing in research collaboration. The urgency of research and development should not compromise the safety of the research participants and the scientific and ethical standards of clinical trials. Research should be conducted under the deliberation and supervision of independent research ethics committees. At the same time, in this global emergency, ethical review process should not delay the research process. Ethical preparedness for global pandemic research encompasses research governance, capacity building for pandemic research review including adaptive efficient operation and timely competent review. In particular, when participating in large-scale global clinical trials involving multiple domestic research institutions, a single IRB familiar with research ethics should take responsibility for ethics review and oversight for the multi-center research. In addition, in light of the truly global nature of the international cooperation in relation to the COVID-19 research, it is of paramount importance to share the benefits of therapeutic and vaccine research. When humanity develops responses and shares resources to cope with COVID-19 through collaboration and solidarity rather than monopoly and competition, the world will overcome the current pandemic together.
|
|
|
KEYWORD
|
|
|
COVID-19, vaccine, pandemic, public health emergency, clinical trial, research ethics
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|